Prevention or reversal of hepatic steatosis by different GLP-1 agonists including exendin-4 [11], [12], liraglutide [13], [14], GLP-1(28–36)amide [15], and AC3174 [16] has been shown in rodents. The gene discussed is GLP1R; the disease is fatty liver disease.